Aptevo Therapeutics: Q4 Earnings Insights


Aptevo Therapeutics APVO reported its Q4 earnings results on Thursday, March 24, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.


Aptevo Therapeutics missed estimated earnings by 3.1%, reporting an EPS of $-1.33 versus an estimate of $-1.29.

Revenue was up $1.29 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 8.71% drop in the share price the next day.

Here's a look at Aptevo Therapeutics's past performance:


Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -1.47 -1.84 1.69 -1.32
EPS Actual -1.43 -1.78 -1.74 -1.77
Revenue Estimate 3.65M 900.00K 2.42M 2.16M
Revenue Actual 3.10M 3.11M 2.42M 2.37M

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!